Besides, since being positive for HER-2 is associated with a higher risk of cancer recurrence (Lowery et al., 2012), women with HER-2 positive breast cancer might require more radical and extensive treatments, such as a mastectomy combined with chemotherapy and targeted therapy, to avoid cancer recurrence and to achieve an improved survival rate. The gene discussed is ERBB2; the disease is breast carcinoma.